Endurant Capital Management LP - Q1 2019 holdings

$253 Million is the total value of Endurant Capital Management LP's 70 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 137.5% .

 Value Shares↓ Weighting
BMY BuyBRISTOL MYERS SQUIBB CO$13,897,000
+441.8%
291,281
+490.4%
5.49%
+305.2%
IIN BuyINTRICON CORP$13,856,000
+111.8%
552,457
+122.8%
5.48%
+58.4%
ICLR BuyICON PLC$13,777,000
+159.2%
100,874
+145.2%
5.45%
+93.9%
VCRA NewVOCERA COMMUNICATIONS INC$12,364,000390,887
+100.0%
4.89%
CI SellCIGNA CORP NEW$10,774,000
-20.0%
66,997
-5.6%
4.26%
-40.2%
SPY NewSPDR S&P 500 ETF TRput$10,480,00037,100
+100.0%
4.14%
GILD NewGILEAD SCIENCES INC$10,128,000155,793
+100.0%
4.00%
ZBH SellZIMMER BIOMET HLDGS INC$9,869,000
-23.2%
77,286
-37.6%
3.90%
-42.6%
TAK NewTAKEDA PHARMACEUTICAL CO LTDsponsored ads$8,911,000437,436
+100.0%
3.52%
BuyFLUIDIGM CORP DELnote 2.750% 2/0$8,191,000
+225.4%
8,756,000
+218.4%
3.24%
+143.5%
HCA NewHCA HEALTHCARE INC$7,833,00060,075
+100.0%
3.10%
WMGI SellWRIGHT MED GROUP N V$7,781,000
+1.3%
247,417
-12.3%
3.08%
-24.2%
RCM SellR1 RCM INC$7,256,000
+2.2%
750,376
-16.0%
2.87%
-23.6%
ATRC NewATRICURE INC$7,142,000266,577
+100.0%
2.82%
ABC BuyAMERISOURCEBERGEN CORP$7,040,000
+1035.5%
88,536
+961.6%
2.78%
+748.5%
LH NewLABORATORY CORP AMER HLDGS$6,864,00044,869
+100.0%
2.71%
AVDR NewAVEDRO INC$5,423,000441,989
+100.0%
2.14%
EVH NewEVOLENT HEALTH INCcl a$5,268,000418,728
+100.0%
2.08%
LIVN NewLIVANOVA PLC$4,115,00042,312
+100.0%
1.63%
IRTC BuyIRHYTHM TECHNOLOGIES INC$3,773,000
+201.4%
50,333
+179.3%
1.49%
+125.4%
XLV NewSELECT SECTOR SPDR TRput$3,734,00040,700
+100.0%
1.48%
THC NewTENET HEALTHCARE CORP$3,513,000121,823
+100.0%
1.39%
ACRS NewACLARIS THERAPEUTICS INC$3,269,000545,729
+100.0%
1.29%
MDT SellMEDTRONIC PLC$3,241,000
-61.6%
35,579
-61.7%
1.28%
-71.3%
QQQ NewINVESCO QQQ TRput$2,982,00016,600
+100.0%
1.18%
CNC NewCENTENE CORP DEL$2,920,00054,995
+100.0%
1.15%
TMO NewTHERMO FISHER SCIENTIFIC INC$2,874,00010,500
+100.0%
1.14%
OCUL BuyOCULAR THERAPEUTIX INC$2,843,000
+207.0%
716,124
+207.7%
1.12%
+129.9%
LMNX NewLUMINEX CORP DEL$2,785,000121,017
+100.0%
1.10%
NTGN NewNEON THERAPEUTICS INC$2,747,000425,291
+100.0%
1.09%
LQDA BuyLIQUIDIA TECHNOLOGIES INC$2,678,000
+215.8%
235,329
+501.3%
1.06%
+136.4%
AGN SellALLERGAN PLC$2,674,000
-83.2%
18,263
-84.7%
1.06%
-87.4%
ANTM NewANTHEM INC$2,607,0009,084
+100.0%
1.03%
BHC SellBAUSCH HEALTH COS INC$2,577,000
-14.9%
104,344
-36.3%
1.02%
-36.3%
VCEL NewVERICEL CORP$2,156,000123,111
+100.0%
0.85%
XENT NewINTERSECT ENT INC$2,108,00065,557
+100.0%
0.83%
KRYS BuyKRYSTAL BIOTECH INC$2,012,000
+673.8%
61,155
+389.2%
0.80%
+480.3%
AXGT NewAXOVANT SCIENCES LTD$1,933,0001,453,314
+100.0%
0.76%
ABT NewABBOTT LABS$1,916,00023,966
+100.0%
0.76%
ALGN NewALIGN TECHNOLOGY INC$1,864,0006,557
+100.0%
0.74%
MRNS NewMARINUS PHARMACEUTICALS INC$1,828,000437,299
+100.0%
0.72%
VKTX BuyVIKING THERAPEUTICS INC$1,774,000
+333.7%
178,448
+233.8%
0.70%
+224.5%
OXFD SellOXFORD IMMUNOTEC GLOBAL PLC$1,768,000
-70.0%
102,593
-77.8%
0.70%
-77.6%
ABBV NewABBVIE INC$1,747,00021,674
+100.0%
0.69%
SRPT SellSAREPTA THERAPEUTICS INC$1,712,000
-27.4%
14,364
-33.5%
0.68%
-45.7%
XRAY SellDENTSPLY SIRONA INC$1,438,000
-67.4%
28,988
-75.5%
0.57%
-75.6%
TVTY NewTIVITY HEALTH INC$1,368,00077,929
+100.0%
0.54%
NewSENSEONICS HLDGS INCnote 5.250% 2/0$1,060,0001,000,000
+100.0%
0.42%
A NewAGILENT TECHNOLOGIES INC$1,011,00012,583
+100.0%
0.40%
OSMT BuyOSMOTICA PHARMACEUTICALS PLC$1,006,000
-44.0%
279,561
+20.5%
0.40%
-58.1%
MOH NewMOLINA HEALTHCARE INC$828,0005,830
+100.0%
0.33%
SIEN NewSIENTRA INC$758,00088,373
+100.0%
0.30%
AXSM SellAXSOME THERAPEUTICS INC$744,000
+26.1%
52,268
-75.0%
0.29%
-5.8%
TDOC NewTELADOC HEALTH INC$731,00013,153
+100.0%
0.29%
VRAY NewVIEWRAY INC$714,00096,580
+100.0%
0.28%
PTCT NewPTC THERAPEUTICS INC$636,00016,903
+100.0%
0.25%
HSIC NewHENRY SCHEIN INC$631,00010,503
+100.0%
0.25%
CVS SellCVS HEALTH CORP$595,000
-93.8%
11,036
-92.5%
0.24%
-95.4%
HAE NewHAEMONETICS CORP$585,0006,691
+100.0%
0.23%
IMGN NewIMMUNOGEN INC$500,000184,440
+100.0%
0.20%
VTGN NewVISTAGEN THERAPEUTICS INC$462,000360,940
+100.0%
0.18%
ANAB SellANAPTYSBIO INC$444,000
-45.3%
6,082
-52.2%
0.18%
-59.0%
SGRY NewSURGERY PARTNERS INC$438,00038,805
+100.0%
0.17%
ARRY SellARRAY BIOPHARMA INC$401,000
-72.5%
16,447
-83.9%
0.16%
-79.4%
BHVN NewBIOHAVEN PHARMACTL HLDG CO L$385,0007,479
+100.0%
0.15%
DVAX NewDYNAVAX TECHNOLOGIES CORP$302,00041,288
+100.0%
0.12%
GRTS NewGRITSTONE ONCOLOGY INC$283,00021,257
+100.0%
0.11%
IMGN NewIMMUNOGEN INCcall$235,00086,800
+100.0%
0.09%
ALDX SellALDEYRA THERAPEUTICS INC$213,000
-61.5%
23,576
-64.6%
0.08%
-71.2%
PTI NewPROTEOSTASIS THERAPEUTICS INcall$165,000130,600
+100.0%
0.06%
MCK ExitMCKESSON CORP$0-4,966
-100.0%
-0.29%
FOLD ExitAMICUS THERAPEUTICS INC$0-58,240
-100.0%
-0.30%
AXGN ExitAXOGEN INC$0-39,961
-100.0%
-0.43%
JNJ ExitJOHNSON & JOHNSON$0-6,588
-100.0%
-0.45%
BSX ExitBOSTON SCIENTIFIC CORP$0-30,560
-100.0%
-0.57%
TEVA ExitTEVA PHARMACEUTICAL INDS LTDsponsored adr$0-73,884
-100.0%
-0.60%
SYK ExitSTRYKER CORP$0-7,319
-100.0%
-0.61%
ARAY ExitACCURAY INC$0-455,018
-100.0%
-0.82%
PETS ExitPETMED EXPRESS INC$0-67,010
-100.0%
-0.82%
FLDM ExitFLUIDIGM CORP DEL$0-236,648
-100.0%
-1.08%
MYL ExitMYLAN N V$0-77,135
-100.0%
-1.12%
NVRO ExitNEVRO CORP$0-54,977
-100.0%
-1.13%
IOVA ExitIOVANCE BIOTHERAPEUTICS INC$0-318,185
-100.0%
-1.49%
PODD ExitINSULET CORP$0-40,727
-100.0%
-1.71%
SNY ExitSANOFIsponsored adr$0-81,401
-100.0%
-1.87%
UNH ExitUNITEDHEALTH GROUP INC$0-16,732
-100.0%
-2.20%
EHC ExitENCOMPASS HEALTH CORP$0-85,272
-100.0%
-2.78%
HOLX ExitHOLOGIC INC$0-135,805
-100.0%
-2.95%
MDRX ExitALLSCRIPTS HEALTHCARE SOLUTN$0-591,533
-100.0%
-3.01%
DVA ExitDAVITA INC$0-140,729
-100.0%
-3.83%
SHPG ExitSHIRE PLCsponsored adr$0-46,100
-100.0%
-4.24%
CELG ExitCELGENE CORP$0-168,609
-100.0%
-5.71%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LABORATORY CORP AMER HLDGS31Q2 20238.7%
ELEVANCE HEALTH INC29Q3 20238.8%
BECTON DICKINSON & CO28Q2 20239.8%
MCKESSON CORP27Q1 20234.4%
CENCORA INC26Q3 20235.9%
HOLOGIC INC24Q3 20237.5%
JOHNSON & JOHNSON24Q4 20215.5%
ZIMMER HLDGS INC23Q3 20237.5%
BOSTON SCIENTIFIC CORP22Q3 20235.5%
DAVITA INC22Q1 20214.9%

View Endurant Capital Management LP's complete holdings history.

Latest significant ownerships (13-D/G)
Endurant Capital Management LP Q1 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AZIYO BIOLOGICS, INC.March 21, 2023576,2534.9%
Oxford Immunotec Global PLCSold outFebruary 17, 202100.0%

View Endurant Capital Management LP's complete significant-ownership history.

Latest filings
TypeFiled
SC 13D/A2024-04-10
13F-HR2024-02-14
13F-HR2023-11-14
SC 13D/A2023-09-08
13F-HR2023-08-14
3/A2023-05-24
13F-HR2023-05-15
32023-05-15
SC 13D2023-05-15
SC 13G/A2023-03-21

View Endurant Capital Management LP's complete filings history.

Compare quarters

Export Endurant Capital Management LP's holdings